Jun 11, 2019 / 05:40PM GMT
Patrick B. Donnelly - Goldman Sachs Group Inc., Research Division - Equity Analyst
All right. Great. Thanks for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Goldman. Happy to have CEO and CFO of Bio-Rad up here, Norm and Ilan. It's certainly open Q&A, so if anyone has any questions in the audience, feel free to just raise your hands, and I'll call out to you. But Norm, maybe just to start, if you can kind of just talk us through the most recent results and then we can jump into Q&A from there.
Norman D. Schwartz - Bio-Rad Laboratories, Inc. - Chairman, CEO & President
So okay. So I think that you started out pretty well. I think we're pretty pleased with the results. I think that when you look around the world, the markets generally has seemed like they're pretty healthy for us for the year.
Questions and Answers:
Patrick B. Donnelly - Goldman Sachs Group Inc., Research Division - Equity AnalystOkay. And then maybe just on the operational side, obviously, we've seen